Patents by Inventor Bradley S. DeHoff

Bradley S. DeHoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8378066
    Abstract: The present invention relates to the preparation of insulinotropic peptides that are synthesized using a solid and solution phase (“hybrid”) approach. Generally, the approach includes synthesizing three different peptide intermediate fragments using solid phase chemistry. Solution phase chemistry is then used to add additional amino acid material to one of the fragments. The fragments are then coupled together in the solution phase. The use of a pseudoproline in one of the fragments eases solid phase synthesis of that fragment and also eases subsequent solution phase coupling of this fragment to other fragments. The present invention is very useful for forming insulinotropic peptides such as Exenatide(1-39) and its natural and non-natural counterparts.
    Type: Grant
    Filed: October 24, 2008
    Date of Patent: February 19, 2013
    Assignee: Corden Pharma Colorado, Inc.
    Inventors: Barry Thomas King, Paul Adam Bury, Richard A. Gabel, John Edward Crider, Robert Thad Carr, II, Bradley S. DeHoff
  • Publication number: 20090149628
    Abstract: The present invention relates to the preparation of insulinotropic peptides that are synthesized using a solid and solution phase (“hybrid”) approach. Generally, the approach includes synthesizing three different peptide intermediate fragments using solid phase chemistry. Solution phase chemistry is then used to add additional amino acid material to one of the fragments. The fragments are then coupled together in the solution phase. The use of a pseudoproline in one of the fragments eases solid phase synthesis of that fragment and also eases subsequent solution phase coupling of this fragment to other fragments. The present invention is very useful for forming insulinotropic peptides such as Exenatide(1-39) and its natural and non-natural counterparts.
    Type: Application
    Filed: October 24, 2008
    Publication date: June 11, 2009
    Inventors: Barry Thomas King, Paul Adam Bury, Richard A. Gabel, John Edward Crider, Robert Thad Carr, II, Bradley S. DeHoff
  • Patent number: 6136971
    Abstract: The present invention provides a process for preparing 1,2-diheteroethylene sulfonamide of the formula: ##STR1## by reacting a pyrimidine monohalide of the formula: ##STR2## with a mono-protected 1,2-diheteroethylene anion of the formula M.sub.1 XCH.sub.2 CH.sub.2 YR.sub.5 and removing the protecting group, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.sub.9, Z, X, Y, M, M.sub.1 and W are defined herein.
    Type: Grant
    Filed: July 15, 1999
    Date of Patent: October 24, 2000
    Assignee: Roche Colorado Corporation
    Inventors: Peter J. Harrington, Hiralal N. Khatri, Bradley S. Dehoff
  • Patent number: 5876991
    Abstract: A DNA molecule isolated from Streptomyces fradiae encodes the multi-functional proteins which direct the synthesis of the polyketide tylactone.
    Type: Grant
    Filed: February 21, 1997
    Date of Patent: March 2, 1999
    Assignee: Eli Lilly and Company
    Inventors: Bradley S. DeHoff, Stuart A. Kuhstoss, Paul R. Rosteck, Jr., Kimberly L. Sutton
  • Patent number: 5191090
    Abstract: An improved process for the synthesis of 2-(2'-thienyl)ethylamine from suitably functionalized derivatives of 2-(2'-thienyl)ethanol employing ammonia gas in the presence of a metal salt or liquid ammonia and alkyl ketone as a solvent. The 2-(2'-thienyl)ethylamine produced by this process is advantageously converted to ticlopidine.
    Type: Grant
    Filed: July 31, 1991
    Date of Patent: March 2, 1993
    Assignee: Syntex (U.S.A.) Inc.
    Inventor: Bradley S. DeHoff
  • Patent number: 5068360
    Abstract: An improved process for the synthesis of 2-(2'-thienyl)ethylamine from suitably functionalized derivatives of 2-(2'-thienyl)ethanol employing ammonia gas in the presence of a metal salt or liquid ammonia and alkyl ketone as a solvent. The 2-(2'-thienyl)ethylamine produced by this process is advantageously converted to ticlopidine.
    Type: Grant
    Filed: January 25, 1990
    Date of Patent: November 26, 1991
    Assignee: Syntex (U.S.A.) Inc.
    Inventor: Bradley S. DeHoff